Interventions study for the control of diabetes mellitus type 2 in obese women
Phase of Trial: Phase IV
Latest Information Update: 27 Aug 2007
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 27 Aug 2007 Status changed from recruiting to completed.
- 27 Mar 2006 New trial record.